Filing Details
- Accession Number:
- 0001209191-21-008244
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2021-02-05 17:59:57
- Reporting Period:
- 2020-12-31
- Accepted Time:
- 2021-02-05 17:59:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632384 | C Joseph Galante | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-20 | 75 | $3.02 | 29,467 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-11-23 | 75 | $3.03 | 29,542 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-11-24 | 75 | $3.03 | 29,617 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-11-25 | 75 | $3.01 | 29,692 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-11-27 | 75 | $3.01 | 29,767 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-11-30 | 75 | $3.05 | 29,842 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-01 | 75 | $3.01 | 29,917 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-02 | 75 | $3.03 | 29,992 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-03 | 75 | $3.02 | 30,067 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-04 | 75 | $3.02 | 30,142 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-07 | 75 | $3.01 | 30,217 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-08 | 75 | $3.05 | 30,292 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-09 | 75 | $3.03 | 30,367 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-10 | 75 | $3.05 | 30,442 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-11 | 75 | $3.04 | 30,517 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-14 | 75 | $3.04 | 30,592 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-15 | 75 | $3.03 | 30,667 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-16 | 75 | $3.03 | 30,742 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-17 | 75 | $3.13 | 30,817 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-18 | 75 | $3.17 | 30,892 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-21 | 75 | $3.15 | 30,967 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-22 | 75 | $3.13 | 31,042 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-23 | 75 | $3.13 | 31,117 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-24 | 75 | $3.11 | 31,192 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-28 | 75 | $3.11 | 31,267 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-29 | 75 | $3.05 | 31,342 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-30 | 75 | $3.08 | 31,417 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020.
- Filing 3 of 3